REVIEW
Accepted on 23 Jul 2025
Advances in the Study of TIM3 in Myelodysplastic Syndrome
doi 10.3389/fimmu.2025.1647401
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Mechanisms and Complexities Underlying the Cancer Cell Immune Evasion and its Therapeutic Implications
Mechanisms and Complexities Underlying the Cancer Cell Immune Evasion and its Therapeutic Implications
1,152
Total downloads
8,370
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 23 Jul 2025
Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
doi 10.3389/fimmu.2025.1627161
- 180 views
MINI REVIEW
Accepted on 19 Jul 2025
M1 macrophages -unexpected contribution to tumor progression
doi 10.3389/fimmu.2025.1638102
- 178 views
ORIGINAL RESEARCH
Published on 10 Jul 2025
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis
doi 10.3389/fimmu.2025.1619361
- 451 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
The heterogeneity of genomic alterations, metastatic patterns and immune microenvironment in metastatic ovarian cancer originating from colorectal cancer
doi 10.3389/fimmu.2025.1593439
- 1,066 views
ORIGINAL RESEARCH
Published on 01 May 2025
Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment
doi 10.3389/fimmu.2025.1547794
- 1,881 views
SYSTEMATIC REVIEW
Published on 25 Apr 2025
Bispecific antibodies combined with chemotherapy in solid tumor treatment, the path forward?
doi 10.3389/fimmu.2025.1568724
- 1,406 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: